Our vision is to become the national leader in healthcare integrated personalized cell technologies for improving health outcomes in children and adults with unmet medical needs.
PACT is excited to announce the opening of its second clinical trial, the first in the U.S. cell-therapy trial for kidney transplant patients.
For more information, please see this press release and clinicaltrials.gov.